A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Conditions: Essential Hypertension; Primary Hypercholesterolemia Interventions: Drug: Fimasartan; Drug: Ezetimibe/Atorvastatin; Drug: Fimasartan Placebo; Drug: Ezetimibe/Atorvastatin Placebo Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials
A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
Condition: Hypercholesterolemia Interventions: Drug: K-877 0.2 mg/day (once daily); Drug: K-877 0.4 mg/day (once daily); Drug: Placebo (once daily) Sponsor: Kowa Company, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials